US Bioservices To Settle Kickback Claims For $13.4M
US Bioservices will pay $13.4 million to settle government claims that it violated the False Claims Act by encouraging patients to unnecessarily refill prescriptions of the iron chelation drug Exjade in...To view the full article, register now.
Already a subscriber? Click here to view full article